2 - TI Pharma

REFERENCES
1. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids.
Pharmacol Ther. 2002;96(1):23-43.
2. Onwubalili jK, Obineche EN. High incidence of post-transplant diabetes mellitus in a single-centre
study. Nephrol Dial Transplant. 1992;7(4):346-9.
3. McMahon M, Gerich j, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes
Metab Rev. 1988;4(1):17-30.
4. Lambillotte C, Gilon P, Henquin jC. Direct glucocorticoid inhibition of insulin secretion. An in vitro
study of dexamethasone effects in mouse islets. j Clin Invest. 1997;99(3):414-23.
5. Longano CA, Fletcher HP. Insulin release after acute hydrocortisone treatment in mice. Metabolism.
1983;32(6):603-8.
6. Kalhan SC, Adam PA. Inhibitory effect of prednisone on insulin secretion in man: model for
duplication of blood glucose concentration. j Clin Endocrinol Metab. 1975;41(3):600-10.
7. Ogawa A, johnson jH, Ohneda M, McAllister CT, Inman L, Alam T, Unger RH. Roles of insulin resistance
and beta-cell dysfunction in dexamethasone-induced diabetes. j Clin Invest. 1992;90(2):497-504.
8. Beard jC, Halter jB, Best jD, Pfeifer MA, Porte D, jr. Dexamethasone-induced insulin resistance
enhances B cell responsiveness to glucose level in normal men. Am j Physiol. 1984;247(5 Pt
1):E592-6.
9. Grill V, Pigon j, Hartling SG, Binder C, Efendic S. Effects of dexamethasone on glucose-induced insulin
and proinsulin release in low and high insulin responders. Metabolism. 1990;39(3):251-8.
10. Henriksen jE, Alford F, Ward GM, Beck-Nielsen H. Risk and mechanism of dexamethasone-induced
deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Diabetologia. 1997;40(12):1439-48.
11. Larsson H, Ahren B. Insulin resistant subjects lack islet adaptation to short-term dexamethasoneinduced
reduction in insulin sensitivity. Diabetologia. 1999;42(8):936-43.
12. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S. The diabetogenic effects of glucocorticoids are more
pronounced in low- than in high-insulin responders. Proc Natl Acad Sci U S A. 1992;89(13):6035-9.
13. Khan A, Ostenson CG, Berggren PO, Efendic S. Glucocorticoid increases glucose cycling and inhibits
insulin release in pancreatic islets of ob/ob mice. Am j Physiol. 1992;263(4 Pt 1):E663-6.
14. Ohneda M, johnson jH, Inman LR, Unger RH. GLUT-2 function in glucose-unresponsive beta cells of
dexamethasone-induced diabetes in rats. j Clin Invest. 1993;92(4):1950-6.
15. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes.
1997;46(1):3-10.
87
4
Chapter 4